The company is a development stage biotechnology play that hasn’t had the easiest ride of late, with the difficulties primarily rooted in some unjustified (and in many cases outright incorrect) coverage of the stock across the financial press.
We must be getting very close to something big happening. Take note off all the new scummy shorts coming out today to comment. Hold tight we are about to go parabolic.